Press Release: GLOBAL REGULATORY PARTNERS EXPANDS ITS FOOTPRINT IN APAC REGION BY OPENING NEW BRANCH OFFICE IN SOUTH KOREA

On January 10, 2022- Global Regulatory Partners Inc, a leading provider of Regulatory Affairs, Clinical development and Compliance services for pharma, biotech, medical device and cosmetic industries worldwide, is pleased to announce the official inauguration of its new branch in Seoul, South Korea.

“Opening a new branch in South Korea, is part of our Global Business Growth Strategy that will be focused, on expanding our footprint in APAC region and strengthening our position in China and Japan. Our main goal is to offer more and better services to our existing and new clients in APAC region and do whatever we can to facilitate their market access and success in APAC region”  

South Korea Brochure

The Ministry of Food and Drug Safety, formerly known as the Korea Food & Drug Administration, is the government agency responsible for the safety and efficiency of foods, pharmaceuticals, medical devices and cosmetics in South Korea. Global Regulatory Partners South Korea has a local team of regulatory affairs, medical, quality and pharmacovigilance professionals we provide tailored services to our clients in South Korea in compliance with the Ministry of Food and Drug Safety (MFDS) regulations.

About Global Regulatory Partners

Global Regulatory Partners, Inc is a leading provider of tailored Regulatory Affairs, Clinical and Compliance services for pharma, biotech and medical device industries worldwide.

We support our client from early stages of their products’ development, through clinical development, products’ registration, and lifecycle maintenance, by providing them tailored regulatory affairs, clinical and compliance services that meet their needs and facilitate their access to different markets.

Global Regulatory Partners. Inc, has now over 250 employees, 6 offices in 6 countries (USA, Brazil, Mexico, Japan, China and South Korea) and more than 600 satisfied clients worldwide.